View Older Stories View More Recent Stories

May 29, 2025 07:30AM Vima Therapeutics Launches to Advance the First Oral Therapy for People with Dystonia and Related Movement Disorders
May 21, 2025 08:00AM Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025
May 17, 2025 08:00AM Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia
May 14, 2025 04:15PM Form 13F-HR Atlas Venture Life Scien For: Mar 31
May 9, 2025 06:00AM Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025
May 8, 2025 11:01AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 8, 2025 10:58AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 8, 2025 10:53AM Form 13F-NT Atlas Venture Fund VIII, For: Mar 31
May 8, 2025 10:48AM Form 13F-HR Atlas Venture Advisors, For: Mar 31
May 6, 2025 05:15PM Form 144 Jade Biosciences, Inc. Filed by: Atlas Venture Associates XII, L.P.
May 6, 2025 05:11PM Form 144 Jade Biosciences, Inc. Filed by: Atlas Venture Fund XII, L.P.
Apr 30, 2025 04:29PM Form SCHEDULE 13D/A Aerovate Therapeutics, Filed by: Atlas Venture Fund XII, L.P.
Apr 28, 2025 04:35PM Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Apr 23, 2025 08:00AM Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025
Apr 17, 2025 11:00AM Scion Life Sciences Expands Team with Appointment of Three Venture Partners
Apr 15, 2025 07:00AM Remix Therapeutics Appoints Linda C. Bain to Board of Directors
Apr 7, 2025 09:00AM Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
Apr 7, 2025 02:00AM Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director
Mar 3, 2025 09:00AM Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer
Feb 19, 2025 09:16AM NAYA Biosciences (NAYA) nominates new Board members
Feb 19, 2025 09:15AM NAYA Biosciences Announces Nomination of New Board Members
Feb 18, 2025 04:59PM Form SCHEDULE 13D Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
Feb 18, 2025 03:30AM LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
Feb 11, 2025 12:12PM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 11, 2025 12:08PM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 11, 2025 12:02PM Form 13F-NT Atlas Venture Fund VIII, For: Dec 31
Feb 11, 2025 11:59AM Form 13F-HR Atlas Venture Advisors, For: Dec 31
Feb 10, 2025 04:05PM Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Atlas Venture Associates Opportunity II, LLC
Feb 6, 2025 09:13PM Form 3 Sionna Therapeutics, For: Feb 06 Filed by: Atlas Venture Fund XI, L.P.
Feb 6, 2025 04:59PM Form 13F-HR Atlas Venture Life Scien For: Dec 31
Feb 6, 2025 09:00AM Be Biopharma Announces Publication of Manuscript in the Molecular Therapy Journal Demonstrating In Vivo Engraftment and Tracking of Ex-vivo-Generated Plasma Cells in Non-Human Primates
Feb 5, 2025 04:06PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Feb 4, 2025 05:14PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Feb 3, 2025 04:28PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Jan 29, 2025 08:00AM Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment
Jan 15, 2025 09:00AM Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
Jan 9, 2025 08:15AM Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer
Jan 9, 2025 07:00AM Arkuda Therapeutics Announces Option Exercise and Asset Purchase
Jan 8, 2025 09:00AM Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer
Jan 7, 2025 09:00AM Be Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 11, 2024 07:00AM Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
Dec 8, 2024 09:00PM Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024
Dec 5, 2024 11:44AM Form D Atlas Venture Fund XIV,
Dec 5, 2024 07:00AM Atlas Venture Announces $450 Million Fund XIV
Dec 3, 2024 08:00AM K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and Other Developmental Compounds at the 66th American Society of Hematology (ASH) Annual Mee
Nov 18, 2024 08:00AM Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024
Nov 14, 2024 04:33PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Nov 14, 2024 04:32PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Nov 14, 2024 04:31PM Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Nov 14, 2024 04:30PM Form SC 13G/A Day One Biopharmaceutica Filed by: Atlas Venture Fund XI, L.P.
View More Recent Stories View Older Stories